Flow cytometric assessment of the signaling status of human B lymphocytes from normal and autoimmune individuals.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 14979930)

Published in Arthritis Res Ther on February 05, 2004

Authors

Amrie C Grammer1, Randy Fischer, Olivia Lee, Xuan Zhang, Peter E Lipsky

Author Affiliations

1: B Cell Biology Group in the National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA. grammera@mail.nih.gov

Articles cited by this

Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry A (2003) 4.45

Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci U S A (1998) 3.35

Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol (1991) 2.56

Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry. Nat Biotechnol (2002) 2.43

NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity (2001) 2.38

A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci U S A (1998) 2.31

GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells. Immunity (2003) 2.18

Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. Immunity (1998) 2.16

The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity. J Immunol (2002) 1.99

Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions. J Clin Invest (2003) 1.63

Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum Mol Genet (1999) 1.50

Genome scan of human systemic lupus erythematosus by regression modeling: evidence of linkage and epistasis at 4p16-15.2. Am J Hum Genet (2000) 1.47

Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: potential for pharmacodynamic monitoring of signal transduction inhibitors. Cytometry (2001) 1.36

Rewiring the T-cell: signaling defects and novel prospects for the treatment of SLE. Trends Immunol (2003) 1.35

Detection of intracellular phosphorylated STAT-1 by flow cytometry. Clin Immunol (1999) 1.34

Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling. Nat Immunol (2003) 1.30

CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms. Adv Immunol (2000) 1.20

Transcriptional regulatory cascades controlling plasma cell differentiation. Immunol Rev (2003) 1.19

Abnormal B cell signal transduction in systemic lupus erythematosus. Curr Dir Autoimmun (2003) 1.15

The AIDS disease of CD4C/HIV transgenic mice shows impaired germinal centers and autoantibodies and develops in the absence of IFN-gamma and IL-6. Immunity (2001) 1.14

Detection of intracellular phosphorylated STAT-4 by flow cytometry. Clin Immunol (2001) 1.10

Regulatory defects in Cbl and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells. J Immunol (2000) 1.07

Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets--definition and detection of ticlopidine/clopidogrel effects. Thromb Haemost (1999) 1.07

p38 MAPK is a critical regulator of the constitutive and the beta4 integrin-regulated expression of IL-6 in human normal thymic epithelial cells. Eur J Immunol (2003) 1.05

Flow cytometric measurement of phosphorylated STAT5 in AML: lack of specific association with FLT3 internal tandem duplications. Leuk Res (2003) 1.02

Expression, regulation, and function of B cell-expressed CD154 in germinal centers. J Immunol (1999) 1.01

CD154-CD40 interactions mediate differentiation to plasma cells in healthy individuals and persons with systemic lupus erythematosus. Arthritis Rheum (2002) 0.98

In situ detection of activated Bruton's tyrosine kinase in the Ig signaling complex by phosphopeptide-specific monoclonal antibodies. Proc Natl Acad Sci U S A (1999) 0.98

Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression. Clin Exp Immunol (1992) 0.96

TNF receptor-associated factor-3 signaling mediates activation of p38 and Jun N-terminal kinase, cytokine secretion, and Ig production following ligation of CD40 on human B cells. J Immunol (1998) 0.93

Immunofluorescent quantification of tyrosine phosphorylation of cellular proteins in whole cells by flow cytometry. Cytometry (1994) 0.84

B lymphocytes and systemic lupus erythematosus. Curr Rheumatol Rep (2003) 0.84

Flow cytometric detection of total and serine 473 phosphorylated Akt. J Cell Biochem (2002) 0.80

Flow cytometric analysis of protein-tyrosine phosphorylation in peripheral T cell subsets. Application to healthy and HIV-seropositive subjects. J Immunol Methods (1995) 0.79

Measurement of protein tyrosine phosphorylation in T-cell subsets by flow cytometry. Methods Mol Biol (2000) 0.77

Analysis by flow cytometry of tyrosine-phosphorylated proteins in activated T-cell subsets on whole blood samples. Cytometry (1997) 0.77

Evidence that increases in lymphocyte tyrosine phosphorylation precede cardiac allograft rejection. Effects of cyclosporine and potential use in clinical management. Transplantation (1994) 0.77

Articles by these authors

TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood (2006) 4.63

Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol (2004) 4.43

IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J Immunol (2005) 4.04

Identification and characterization of circulating human transitional B cells. Blood (2005) 3.62

Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol (2007) 3.49

NCBI Epigenomics: a new public resource for exploring epigenomic data sets. Nucleic Acids Res (2010) 3.27

Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol (2007) 3.22

Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA (2011) 3.05

Characterization of the human Ig heavy chain antigen binding complementarity determining region 3 using a newly developed software algorithm, JOINSOLVER. J Immunol (2004) 2.62

Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration. J Immunol (2007) 2.56

Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood (2009) 2.46

Magnetic resonance imaging in the evaluation of bone damage in rheumatoid arthritis: a more precise image or just a more expensive one? Arthritis Rheum (2003) 2.37

Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum (2003) 2.32

The acute nociceptive signals induced by bradykinin in rat sensory neurons are mediated by inhibition of M-type K+ channels and activation of Ca2+-activated Cl- channels. J Clin Invest (2010) 2.16

Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood (2010) 2.15

The role of IL-21 in regulating B-cell function in health and disease. Immunol Rev (2008) 2.09

Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27. J Immunol (2005) 2.01

ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice. Am J Physiol Heart Circ Physiol (2009) 2.01

Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein. J Exp Med (2005) 2.00

Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. Arthritis Rheum (2008) 2.00

Anti-basal ganglia antibodies in PANDAS. Mov Disord (2004) 1.98

Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum (2006) 1.87

Gastrointestinal involvement in systemic lupus erythematosus: insight into pathogenesis, diagnosis and treatment. World J Gastroenterol (2010) 1.87

Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study. Arthritis Rheum (2010) 1.86

Integrative approaches for predicting microRNA function and prioritizing disease-related microRNA using biological interaction networks. Brief Bioinform (2015) 1.82

Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. Arthritis Rheum (2002) 1.81

Neuronal injury in rat model of permanent focal cerebral ischemia is associated with activation of autophagic and lysosomal pathways. Autophagy (2008) 1.78

Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain. Int J Dev Neurosci (2009) 1.76

Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). Phytochemistry (2007) 1.74

Revisiting the ancient concept of botanical therapeutics. Nat Chem Biol (2007) 1.71

Comparison of antibody repertoires produced by HIV-1 infection, other chronic and acute infections, and systemic autoimmune disease. PLoS One (2011) 1.68

The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors. J Immunol (2005) 1.66

Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjögren's syndrome. Arthritis Rheum (2005) 1.65

Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions. J Clin Invest (2003) 1.63

IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells. J Immunol (2007) 1.62

Identification and characterization of a human CD5+ pre-naive B cell population. J Immunol (2009) 1.59

A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. Blood (2003) 1.54

Mechanisms of B cell autoimmunity in SLE. Arthritis Res Ther (2011) 1.53

Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial. Ann Intern Med (2009) 1.53

Effect of a culturally sensitive cholesterol lowering diet program on lipid and lipoproteins, body weight, nutrient intakes, and quality of life in patients with systemic lupus erythematosus. J Rheumatol (2002) 1.49

The suppression of WRKY44 by GIGANTEA-miR172 pathway is involved in drought response of Arabidopsis thaliana. PLoS One (2013) 1.48

Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum (2002) 1.47

The role of the T cell in autoimmune inflammation. Arthritis Res Ther (2005) 1.46

Immunopathogenesis of primary Sjögren's syndrome: implications for disease management and therapy. Curr Opin Rheumatol (2005) 1.46

CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases. Nat Clin Pract Rheumatol (2007) 1.42

Pyocystis after urinary diversion for incontinence--is a concomitant cystectomy necessary? Urology (2013) 1.42

Enhancement of avermectin and ivermectin production by overexpression of the maltose ATP-binding cassette transporter in Streptomyces avermitilis. Bioresour Technol (2010) 1.42

Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation. Cell Res (2012) 1.39

Potential neurotoxicity of ketamine in the developing rat brain. Toxicol Sci (2009) 1.33

Striatal microinfusion of Tourette syndrome and PANDAS sera: failure to induce behavioral changes. Mov Disord (2004) 1.32

Abnormalities of B cell subsets in patients with systemic lupus erythematosus. J Immunol Methods (2010) 1.30

Inhalation anesthetic-induced neuronal damage in the developing rhesus monkey. Neurotoxicol Teratol (2011) 1.30

Androgen increases AT1a receptor expression in abdominal aortas to promote angiotensin II-induced AAAs in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2008) 1.29

Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor. Arthritis Res Ther (2009) 1.27

Anti-inflammatory and immunosuppressive compounds from Tripterygium wilfordii. Phytochemistry (2007) 1.26

A high-mobility electron-transport polymer with broad absorption and its use in field-effect transistors and all-polymer solar cells. J Am Chem Soc (2007) 1.25

Biomarkers in systemic lupus erythematosus. I. General overview of biomarkers and their applicability. Arthritis Rheum (2004) 1.25

SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature. PLoS One (2013) 1.25

Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic. J Control Release (2005) 1.24

TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-{kappa}B activation. J Biol Chem (2004) 1.24

The low affinity IgE receptor (CD23) is cleaved by the metalloproteinase ADAM10. J Biol Chem (2007) 1.21

Secondary immunization generates clonally related antigen-specific plasma cells and memory B cells. J Immunol (2010) 1.20

Biomarkers in systemic lupus erythematosus: II. Markers of disease activity. Arthritis Rheum (2004) 1.20

Dendritic cells, chemokine receptors and autoimmune inflammatory diseases. Immunol Cell Biol (2002) 1.19

A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren's syndrome at 7q11.23. Nat Genet (2013) 1.19

Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells? Arthritis Res Ther (2009) 1.19

New concepts in the pathogenesis of Sjögren syndrome: many questions, fewer answers. Curr Opin Rheumatol (2003) 1.19

Chemokine receptor expression and functional effects of chemokines on B cells: implication in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther (2009) 1.19

B-cell lymphoproliferation in chronic inflammatory rheumatic diseases. Nat Clin Pract Rheumatol (2007) 1.18

Association of the IL4R single-nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritis. Arthritis Rheum (2006) 1.17

Dynamics of persistent and acute deformed wing virus infections in honey bees, Apis mellifera. Viruses (2011) 1.17

MicroRNA-134 plasma levels before and after treatment for bipolar mania. J Psychiatr Res (2010) 1.17

B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res Ther (2007) 1.16

B cell abnormalities in systemic lupus erythematosus. Arthritis Res Ther (2003) 1.15

Relative Risk for HIV Infection Among Men Who Have Sex with Men Engaging in Different Roles in Anal Sex: A Systematic Review and Meta-analysis on Global Data. AIDS Behav (2015) 1.14

Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patients. J Neuroimmunol (2005) 1.14

B cells in autoimmunity. Arthritis Res Ther (2009) 1.13

Trends in HIV prevalence among men who have sex with men in China 2003-09: a systematic review and meta-analysis. Sex Health (2013) 1.13

p53 mediates mitochondria dysfunction-triggered autophagy activation and cell death in rat striatum. Autophagy (2009) 1.11

The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles. Biomaterials (2011) 1.11

T cell-dependent survival of CD20+ and CD20- plasma cells in human secondary lymphoid tissue. Blood (2007) 1.11

Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targeting. Blood (2008) 1.11

Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout. Arthritis Res Ther (2014) 1.10

Generation of human regulatory gammadelta T cells by TCRgammadelta stimulation in the presence of TGF-beta and their involvement in the pathogenesis of systemic lupus erythematosus. J Immunol (2011) 1.10

Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus. Ann Rheum Dis (2012) 1.10

GATA-3 in human T cell helper type 2 development. J Exp Med (2004) 1.09

Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice. Arterioscler Thromb Vasc Biol (2012) 1.09

Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene. Blood (2002) 1.09

Abnormalities in peripheral B cell memory of patients with primary Sjögren's syndrome. Arthritis Rheum (2004) 1.08

Role of the spleen in peripheral memory B-cell homeostasis in patients with autoimmune thrombocytopenia purpura. Clin Immunol (2008) 1.07

Measurement of two caspase activities simultaneously in living cells by a novel dual FRET fluorescent indicator probe. Cytometry A (2006) 1.07

Criteria for early rheumatoid arthritis: from Bayes' law revisited to new thoughts on pathogenesis. Arthritis Rheum (2002) 1.07

Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo. J Pharm Sci (2005) 1.06

Abnormal differentiation of memory T cells in systemic lupus erythematosus. Arthritis Rheum (2006) 1.06

Are autoantibodies the targets of B-cell-directed therapy? Nat Rev Rheumatol (2011) 1.05

Developmental changes in the human heavy chain CDR3. J Immunol (2005) 1.04

Prospective cohort study of comprehensive prevention to gastric cancer. World J Gastroenterol (2003) 1.04